SCHEMBL20156062

SCHEMBL20156062

Oc1cnn(O)c1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 5/20 0.49
GABRB2 P47870 5/20 0.49
BACE1 P56817 1/20 0.38
HPGD P15428 2/20 0.37
BCL2L1 Q07817 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPK1 P28482 3/20 0.36
POLB P06746 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
USP2 O75604 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MMP3 P08254 1/20 0.34
ALOX5 P09917 2/20 0.34
KDM4E B2RXH2 1/20 0.34
MAPT P10636 1/20 0.34
XBP1 P17861 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23402261 0.78 HIF1A (0.42) BACE1HPGDALDH1A1HSD17B10SMN1; SMN2
SCHEMBL14495383 0.76 ALDH1A1 (0.50) ALDH1A1MAPK1MEN1KMT2APTGS1
SCHEMBL23403250 0.73 HTR2A (0.40) BACE1HPGDBCL2L1ALDH1A1HSD17B10
SCHEMBL23400670 0.73 PTGIR (0.42) HPGDALDH1A1MAPK1POLBATM
SCHEMBL23399704 0.73 HTR2A (0.40) BACE1HPGDALDH1A1SMN1; SMN2GAA
SCHEMBL472924 0.71 MAPK1 (0.45) GABRA1GABRB2BACE1BCL2L1MAPK1
SCHEMBL23399927 0.71 PTGIR (0.47) ALDH1A1MAPK1POLBMEN1KMT2A
SCHEMBL23403184 0.70 ALDH1A1 (0.47) ALDH1A1L3MBTL1MEN1KMT2ASMN1; SMN2
SCHEMBL23399782 0.70 PTGS2 (0.52) ALDH1A1KMT2AMAPTPTGS1PTGS2
SCHEMBL23400063 0.70 S1PR1 (0.46) ALDH1A1MAPK1SMN1; SMN2MAPTPTGIR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089358-A1 AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed